Literature DB >> 9727994

What can be done about resistance to antibiotics?

J Turnidge1.   

Abstract

Mesh：

Year:  1998        PMID： 9727994      PMCID： PMC1113833          DOI： 10.1136/bmj.317.7159.645

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  20 in total

1.  Methicillin-resistant Staphylococcus aureus--a reappraisal.

Authors:  C T Keane; D C Coleman; M T Cafferkey
Journal:  J Hosp Infect       Date:  1991-11       Impact factor: 3.926

2.  Antibiotic use and antibiotic resistance worldwide. Report of a study sponsored by the Fogarty International Center of the National Institutes of Health, 1983-1986.

Authors: 
Journal:  Rev Infect Dis       Date:  1987 May-Jun

3.  Confronting multidrug resistance. A role for each of us.

Authors:  S B Levy
Journal:  JAMA       Date:  1993-04-14       Impact factor: 56.272

4.  Hungary sees an improvement in penicillin resistance.

Authors:  R Nowak
Journal:  Science       Date:  1994-04-15       Impact factor: 47.728

5.  Can antibiotic resistance be controlled?

Authors:  B E Murray
Journal:  N Engl J Med       Date:  1994-04-28       Impact factor: 91.245

Review 6.  Recommendations for preventing the spread of vancomycin resistance.

Authors: 
Journal:  Infect Control Hosp Epidemiol       Date:  1995-02       Impact factor: 3.254

7.  Treatment of acute otitis media with a shortened course of antibiotics: a meta-analysis.

Authors:  A L Kozyrskyj; G E Hildes-Ripstein; S E Longstaffe; J L Wincott; D S Sitar; T P Klassen; M E Moffatt
Journal:  JAMA       Date:  1998-06-03       Impact factor: 56.272

8.  Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991.

Authors:  A L Panlilio; D H Culver; R P Gaynes; S Banerjee; T S Henderson; J S Tolson; W J Martone
Journal:  Infect Control Hosp Epidemiol       Date:  1992-10       Impact factor: 3.254

Review 9.  Vancomycin-resistant Staphylococcus aureus: perspectives on measures needed for control.

Authors:  M B Edmond; R P Wenzel; A W Pasculle
Journal:  Ann Intern Med       Date:  1996-02-01       Impact factor: 25.391

10.  The emergence of erythromycin resistance in Streptococcus pyogenes in Fremantle, Western Australia.

Authors:  N Stingemore; G R Francis; M Toohey; D B McGechie
Journal:  Med J Aust       Date:  1989-06-05       Impact factor: 7.738
View more
  6 in total

Review 1.  Infection and antimicrobial prescribing control in the new millennium: nightmare or nirvana?

Authors:  B Cookson
Journal:  J Clin Pathol       Date:  2000-01       Impact factor: 3.411

2.  Management of urinary tract infection in general practice: a cost-effectiveness analysis.

Authors:  E A Fenwick; A H Briggs; C I Hawke
Journal:  Br J Gen Pract       Date:  2000-08       Impact factor: 5.386

3.  Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain.

Authors:  E Pérez-Trallero; C Fernández-Mazarrasa; C García-Rey; E Bouza; L Aguilar; J García-de-Lomas; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

4.  Applying pharmacokinetic/pharmacodynamic measurements for linezolid in critically ill patients: optimizing efficacy and reducing resistance occurrence.

Authors:  Rasha M El-Gaml; Noha M El-Khodary; Rania R Abozahra; Ayman A El-Tayar; Soha M El-Masry
Journal:  Eur J Clin Pharmacol       Date:  2022-05-25       Impact factor: 3.064

5.  A qualitative study of patients' perceptions of acute infective conjunctivitis.

Authors:  Hazel Everitt; Satinder Kumar; Paul Little
Journal:  Br J Gen Pract       Date:  2003-01       Impact factor: 5.386

6.  Do physician outcome judgments and judgment biases contribute to inappropriate use of treatments? Study protocol.

Authors:  Jamie C Brehaut; Roy Poses; Kaveh G Shojania; Alison Lott; Malcolm Man-Son-Hing; Elise Bassin; Jeremy Grimshaw
Journal:  Implement Sci       Date:  2007-06-07       Impact factor: 7.327
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.